Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient.
We report the third case in the literature of a patient with a long-lasting renal allograft who experienced tuberculosis just after the switch from azathioprine to mycophenolate mofetil. The switch was likely responsible for the reactivation of dormant tuberculosis; prophylactic antituberculous treatment should be considered in cases of such a therapeutic change.
Mercadal
L
L
Department of Nephrology, Pitié-Salpétrière Hospital, Paris, France. lucile.mercadal@psl.ap-hop-paris.fr
Foltz
V
V
Isnard-Bagnis
C
C
Ourahma
S
S
Deray
G
G
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy
D000995:Antitubercular Agents; D009173:Mycophenolic Acid; D001379:Azathioprine